Target intelligence / Profile preview

Cell division cycle-associated protein 5 (CDCA5)

Target
CDCA5
Molecular classification
Other (specifically, regulator of sister chromatid cohesion; not a typical receptor, enzyme, transporter, or transcription factor)
01

Overview

Cell division cycle-associated protein 5 (CDCA5), also known as Sororin, is a small, evolutionarily conserved phosphoprotein that plays a central role in the maintenance of sister chromatid cohesion from S phase to the onset of anaphase in the cell cycle[1][2][3][4]. Sororin stabilizes the association between the cohesin complex and chromatin, antagonizes the activity of the cohesin release factor Wapl, and is critical for proper chromosome segregation[1][2][4]. CDCA5 is dynamically regulated and is degraded by the anaphase-promoting complex during exit from mitosis[2]. Overexpression of CDCA5 has been associated with several human cancers and is considered a poor prognostic biomarker[2]. CDCA5 is essential for early embryonic development and normal cell proliferation, suggesting that its inhibition may lead to safety concerns or toxicity. There are currently no known drugs that directly target CDCA5; its biological role makes it a potential, but challenging, therapeutic target in oncology[2][4].

Other names
Sororinp35SORORINCDCA5cell division cycle-associated protein 5sororin
02

Biological functions

Cell cycleDNA repairCell proliferationSister chromatid cohesion
03

Disease associations

CancerCornelia de Lange syndromeRobert-Sc phocomelia syndrome
04

Safety considerations

Potential risk related to targeting because CDCA5 is essential for normal cell cycle progression and embryonic development
05

Biomarkers

Poor prognostic biomarker for multiple cancers (lung, urothelial carcinoma, oral squamous cell carcinoma, gastric cancer, hepatocellular carcinoma, breast cancer)

Beyond the preview

Go deeper on Cell division cycle-associated protein 5 (CDCA5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell division cycle-associated protein 5 (CDCA5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call